Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Investigator Blind, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of APC-231 Sprinkle QD for 7 Days vs Penicillin VK 10 mg/kg QID for 10 Days in Pediatric Patients With Streptococcus Pyogenes

NCT00100126 is registered in ClinicalTrials.gov with Advancis Pharmaceutical Corporation as lead sponsor.

NCT NCT00100126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00100126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Investigator Blind, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of APC-231 Sprinkle QD for 7 Days vs Penicillin VK 10 mg/kg QID for 10 Days in Pediatric Patients With Streptococcus Pyogenes
Lead sponsor
Advancis Pharmaceutical Corporation
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2004
Completion date
June 30, 2005
Enrollment
500
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pharyngitis